Cited by 1,192Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Friberg, Leif, Rosenqvist, Mårten, Lip, Gregory Y.H.·2012·European Heart Journal

DOI 10.1093/eurheartj/ehr488

Open this paper in CoChat — free account

Abstract

Aims The impact of some risk factors for stroke and bleeding, and the value of stroke and bleeding risk scores, in atrial fibrillation (AF), has been debated, as clinical trial cohorts have not adequately tested these. Our objective was to investigate risk factors for stroke and bleeding in AF, and application of the new CHA(2)DS(2)-VASc and HAS-BLED schemes for stroke and bleeding risk assessments, respectively. Methods and results We used the Swedish Atrial Fibrillation cohort study, a nationwide cohort study of 182 678 subjects with a diagnosis of AF at any Swedish hospital between 1 July 2005 and 31 December 2008, who were prospectively followed for an average of 1.5 years (260 000 years at risk). With the use of the National Swedish Drug Registry, all patients who used an oral anticoagulant anytime during follow-up were identified. Most of the analyses were made on a subset of 90 490 patients who never used anticoagulants. Risk factors for stroke, the composite thromboembolism endpoint (stroke, TIA, or systemic embolism), and bleeding, and the performance of published stroke and bleeding risk stratification schemes were investigated. On multivariable analysis, significant associations were found between the following 'new' risk factors and thromboembolic events; peripheral artery disease [hazard ratio (HR) 1.22 (95% CI 1.12-1.32)], 'vascular disease' [HR 1.14 (1.06-1.23)], prior myocardial infarction [HR 1.09 (1.03-1.15)], and female gender [HR 1.17 (1.11-1.22)]. Previou…

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr488

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citation
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Self-citation
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929)
Greenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,077
Self-citation

Show all 48 references

Research works printed but not linked: 2

Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised clinical trials, Arch Intern Med, 154, 1949
National Collaborating Centre for Chronic Conditions, 2006, Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care

Sorted by citations

Items 301–400 of 999

Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study
Chen, P., Lip, G. Y. H., Yeh, G., Lin, H., & Chien, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125257 · Cited by 31
Self-citation
Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis
Koifman, E., Lipinski, M. J., Escarcega, R. O., Didier, R. J., Kiramijyan, S., Torguson, R., & Waksman, R. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.11.181 · Cited by 33
Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation
Allende, M., Molina, E., González‐Porras, J. R., Toledo, E., Lecumberri, R., & Hermida, J. (2016) · Stroke · doi:10.1161/strokeaha.115.011837 · Cited by 31
Perioperative Atrial Fibrillation in Noncardiac Surgeries for Malignancies and One-Year Recurrence
Higuchi, S., Kabeya, Y., Matsushita, K., Arai, N., Tachibana, K., Tanaka, R., Kawachi, R., Takei, H., Suzuki, Y., Kogure, M., et al. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.07.008 · Cited by 31
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy)
Poli, L., Grassi, M., Zedde, M., Marcheselli, S., Silvestrelli, G., Sessa, M., Zini, A., Paciaroni, M., Azzini, C., Gamba, M., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1627454 · Cited by 31
Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population
Lee, J., Kim, T., Cha, M., Park, J., Park, J., Kang, K., Shim, J., Uhm, J., Kim, J., Park, H. W., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2017.0389 · Cited by 31
Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool
Shantsila, E., Wolff, A., Lip, G. Y. H., & Lane, D. A. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12625 · Cited by 30
Self-citation
Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease?
McAlister, F. A., Wiebe, N., Jun, M., Sandhu, R. K., James, M. T., McMurtry, M. S., Hemmelgarn, B. R., & Tonelli, M. A. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.08.018 · Cited by 33
Anticoagulation of Cardiovascular Conditions in the Cancer Patient: Review of Old and New Therapies
Rhea, I. B., Lyon, A. R., & Fradley, M. G. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0797-z · Cited by 30
Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study
Poli, D., Antonucci, E., Ageno, W., Bertù, L., Migliaccio, L., Martinese, L., Pilato, G., Testa, S., & Palareti, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216831 · Cited by 31
Clinical Outcomes of Mortality, Readmissions, and Ischemic Stroke Among Medicare Patients Undergoing Left Atrial Appendage Closure via Implanted Device
Kabra, R., Girotra, S. R., & Vaughan‐Sarrazin, M. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.14268 · Cited by 30
Shared decision-making tool for thromboprophylaxis in atrial fibrillation – A feasibility study
Eckman, M. H., Costea, A., Attari, M., Munjal, J., Wise, R. E., Knochelmann, C., Flaherty, M. L., Baker, P., Ireton, R., Harnett, B. M., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.01.003 · Cited by 30
Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis
Fassini, G. M., Gasperetti, A., Italiano, G., Riva, S. I., Moltrasio, M., Russo, A. D., Casella, M., Maltagliati, A. C., Tundo, F., Majocchi, B., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.03.022 · Cited by 30
Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary
Lip, G. Y. H. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12140 · Cited by 29
Self-citation
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE‐LY trial
Proietti, M., Hijazi, Z., Andersson, J., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Lane, D. A., Oldgren, J., Roldán, V., Yusuf, S., et al. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12702 · Cited by 29
Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort
Schrag, M., Grory, B. M., Nackenoff, A. G., Eaton, J. E., Mistry, E. A., Kirshner, H. S., Yaghi, S. R., & Ellis, C. R. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00838-5 · Cited by 31
Characterization of patients with atrial fibrillation not treated with oral anticoagulants
Johansson, C., Hägg, L., Johansson, L., & Jansson, J. (2014) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2014.984952 · Cited by 29
Female gender as a risk factor for stroke associated with atrial fibrillation
Camm, A. J., & Savelieva, I. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx103 · Cited by 29
Role of Atrial Fibrillation Burden in Assessing Thromboembolic Risk
ZIMETBAUM, P. J., Waks, J. W., Ellis, E. R., Glotzer, T. V., & PASSMAN, R. S. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001356 · Cited by 28
Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation
Casciano, J. P., Singer, D. E., Kwong, W. J., Fox, E. S., & Martin, B. C. (2012) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03261840 · Cited by 28
Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II
López-Mínguez, J. R., Nogales‐Asensio, J. M., de Oliveira, E. I., Ribeiro, V. G., Ruiz-Salmeron, R. J., Arzamendi, D., Costa, M. A. D. S., Gutiérrez-García, H., Díaz, J. A. F., Martín‐Yuste, V., et al. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.03.017 · Cited by 27
Pre-Diabetes Increases Stroke Risk in Patients With Nonvalvular Atrial Fibrillation
Kezerle, L., Tsadok, M. A., Akriv, A., Senderey, A. B., Bachrach, A., Leventer‐Roberts, M., & Haim, M. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.030 · Cited by 28
Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 34
Self-citation
Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta‐analysis
Jiang, H., Jiang, Y., Ma, H., Zeng, H., & Lv, J. (2021) · Clinical Cardiology · doi:10.1002/clc.23690 · Cited by 27
Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation
Lin, K. J., Singer, D. E., Bykov, K., Bessette, L. G., Mastrorilli, J. M., Cervone, A., & Kim, D. H. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4086 · Cited by 28
Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure
Saw, J., Fahmy, P., Azzalini, L., Marquis, J.-F., Hibbert, B. M., Morillo, C. A., Carrizo, A. G., & Ibrahim, R. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13168 · Cited by 27
Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram
Chao, T., Lu, T., Lin, Y., Tsao, H.-M., Chang, S., Lo, L., Hu, Y., Tuan, T., HSIEH, M., & Chen, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071675 · Cited by 26
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study
Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., Goldhaber, S. Z., & Jensen, M. B. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.037 · Cited by 26
Self-citation
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Jacobs, M. S., van Hulst, M., Campmans, Z., & Tieleman, R. G. (2019) · Netherlands Heart Journal · doi:10.1007/s12471-019-1267-9 · Cited by 26
Utilización de los anticoagulantes orales de acción directa en Atención Primaria de España. Posicionamiento de SEMERGEN ante la situación actual
Caro, J. L. L., Cinza‐Sanjurjo, S., García, J. P., & Prieto-Díaz, M. Á. (2019) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2019.06.002 · Cited by 26
Estimated salt intake and risk of atrial fibrillation in a prospective community‐based cohort
Wuopio, J., Orho‐Melander, M., Ärnlöv, J., & Nowak, C. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13194 · Cited by 27
Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation
Cartledge, R. G., Suwalski, G., Witkowska, A., Gottlieb, G., Cioci, A., Chidiac, G., Ilsin, B., Merrill, B., & Suwalski, P. (2021) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivab334 · Cited by 26
Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation
Labori, F., Persson, J., Bonander, C., Jood, K., & Svensson, M. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab847 · Cited by 26
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke
McIntyre, W. F., Wang, J., Benz, A. P., Johnson, L., Connolly, S. J., Gelder, I. C. V., Lópes, R. D., Gold, M. R., Hohnloser, S. H., Lau, C., et al. (2021) · EP Europace · doi:10.1093/europace/euab324 · Cited by 26
Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022)
Chazova, I. E., Ageev, F. T., Владимировна, А. А., Vicenya, M. V. V., Gilyarov, M. Y., Martynyuk, T. V., Панченко, Е. П., Poltavskaya, M. G., Potievskaya, V. I., Trofimova, O. P., et al. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-1-6-79 · Cited by 33
Hypertension and atrial fibrillation
Middeldorp, M. E., Ariyaratnam, J., Kamsani, S. H., Albert, C. M., & Sanders, P. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003278 · Cited by 27
Preoperative identification of patients with increased risk for perioperative bleeding
Gombotz, H., & Knotzer, H. (2012) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32835b9a23 · Cited by 26
Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: A national wide database analysis
Yang, Y., Shao, X., Zhu, J., Zhang, H., Liu, Y. Z., Gao, X., Liu, L., Yu, L., Zhao, L., Yu, P., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.02.040 · Cited by 26
Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation
Tarride, J., Dolovich, L., Blackhouse, G., Guertin, J. R., Burke, N., Manja, V., Grinvalds, A., Lim, T., Healey, J. S., & Sandhu, R. K. (2017) · CMAJ Open · doi:10.9778/cmajo.20170042 · Cited by 26
Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke
Redfors, B., Gray, W. A., Lee, R. J., Ellenbogen, K. A., Bonafede, M., & Ben‐Yehuda, O. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.04.024 · Cited by 26
Percutaneous Left Atrial Appendage Closure With the Ultraseal Device
Asmarats, L., Masson, J., Pagnotta, P. A., Cook, S., Foresti, M., Ibrahim, R., Sukiennik, A., Sabiniewicz, R., Maffeo, D., Carballo, J., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.05.023 · Cited by 26
Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events
Teíger, E., Thambo, J., Defaye, P., Hermida, J., Abbey, S., Klug, D., Juliard, J., Pasquié, J., Rioufol, G., Lepillier, A., et al. (2018) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.117.005841 · Cited by 26
CARDIAC SURGERY New oral anticoagulants – a practical guide
Ciuruś, T., Sobczak, S., Cichocka‐Radwan, A., & Lelonek, M. (2015) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2015.52851 · Cited by 25
Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation
Banerjee, A., Fauchier, L., Bernard-Brunet, A., Clémenty, N., & Lip, G. Y. H. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-12-1033 · Cited by 25
Self-citation
Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding
Parks, A. L., & Fang, M. C. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1598061 · Cited by 25
Underuse of Oral Anticoagulants and Inappropriate Prescription of Antiplatelet Therapy in Older Inpatients with Atrial Fibrillation
Averlant, L., Ficheur, G., Ferret, L., Boulé, S., Puisieux, F. L., Luyckx, M., Soula, J., Georges, A., Beuscart, R., Chazard, E., et al. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0477-3 · Cited by 25
Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?
Tarride, J., Quinn, F. R., Blackhouse, G., Sandhu, R. K., Burke, N., Gladstone, D. J., Ivers, N. M., Dolovich, L. R., Thornton, A., Nakamya, J., et al. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.05.016 · Cited by 25
The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis
Teppo, K., Jaakkola, J., Lehto, M., Biancari, F., & Airaksinen, J. K. E. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100221 · Cited by 25
Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1
Trohman, R. G., Huang, H. D., & Sharma, P. S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1060030 · Cited by 29
Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation
Eckman, M. H., Wise, R. E., Speer, B. B., Sullivan, M., Walker, N., Lip, G. Y. H., D, B. M. K. M., Flaherty, M. L., Kleindorfer, D., Khan, F., et al. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001163 · Cited by 25
Self-citation
Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation
Shah, S. J., Eckman, M. H., Aspberg, S., Go, A. S., & Singer, D. E. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2762 · Cited by 25
The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome
Lee, H., & Lin, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030891 · Cited by 25
Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries
Loring, Z., Mehrotra, S., Piccini, J. P., Camm, A. J., Carlson, D., Fonarow, G. C., Fox, K. A. A., Peterson, E. D., Pieper, K. S., & Kakkar, A. K. (2020) · EP Europace · doi:10.1093/europace/euaa172 · Cited by 25
Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation
Simon, T. G., Singer, D. E., Zhang, Y., Mastrorilli, J. M., Cervone, A., DiCesare, E., & Lin, K. J. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3067 · Cited by 24
Efficacy of the stand‐alone Cox‐Maze IV procedure in patients with longstanding persistent atrial fibrillation
McGilvray, M. M. O., Bakir, N. H., Kelly, M. O., Perez, S. C., Sinn, L. A., Schuessler, R. B., Zemlin, C. W., Maniar, H. S., Melby, S. J., & Damiano, R. J. (2021) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15113 · Cited by 25
Long-term outcome of combined catheter ablation and left atrial appendage closure in atrial fibrillation patients
Chen, M., Sun, J., Wang, Q., Zhang, P., Li, W., Zhang, R., Mo, B., Yu, Y.-C., Cai, X., Yang, M., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.08.007 · Cited by 24
A Clinical Decision Instrument for 30-Day Death After an Emergency Department Visit for Atrial Fibrillation: The Atrial Fibrillation in the Emergency Room (AFTER) Study
Atzema, C. L., Dorian, P., Fang, J., Tu, J. V., Lee, D. S., Chong, A. S., & Austin, P. C. (2015) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2015.07.017 · Cited by 24
Predictive value of the HAS-BLED score for the risk of recurrent intracranial hemorrhage after first spontaneous intracranial hemorrhage.
Chan, K., Leung, G. K.-K., Lau, K., Liu, S.-S., Lui, W., Lau, C.-P., Tse, H., Pu, J. K.-S., & Siu, C. (2014) · World Neurosurgery · doi:10.1016/j.wneu.2013.02.070 · Cited by 29
Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program
McIntyre, W. F., Conen, D., Olshansky, B., Halperin, J. L., Hayek, E. R., Huisman, M. V., Lip, G. Y. H., Lu, S., & Healey, J. S. (2018) · Clinical Cardiology · doi:10.1002/clc.22936 · Cited by 24
Self-citation
How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism
Chan, N., & Eikelboom, J. W. (2019) · Blood · doi:10.1182/blood-2019-01-846048 · Cited by 24
Atrial Fibrillation in Africa—An Under-Reported and Unrecognized Risk Factor for Stroke: A Systematic Review
Jacobs, M. S., van Hulst, M., Adeoye, A. M., Tieleman, R. G., Postma, M. J., & Owolabi, M. O. (2019) · Global Heart · doi:10.1016/j.gheart.2019.04.003 · Cited by 25
Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients
Marazzato, J., Blasi, F., Golino, M., Verdecchia, P., Angeli, F., & Ponti, R. D. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9040110 · Cited by 23
Validation of Embolic and Bleeding Risk Scores in Patients With Atrial Fibrillation and Cancer
Raposeiras‐Roubín, S., Abu-Assi, E., Marchán-López, Á., Sanz, T. F., Barreiro-Pardal, C., Pousa, I. M., Erquicia, P. D., Piñeiro, A. L., Bermúdez, I. G., Melendo‐Viu, M., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.06.044 · Cited by 23
Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation
Soo, Y. O. Y., Zietz, A., Yiu, B., Mok, V., Polymeris, A. A., Seiffge, D. J., Ambler, G., Wilson, D., Leung, T. W. H., Tsang, S. F., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26642 · Cited by 26
Self-citation
Relationship Between Endothelial Dysfunction and the Outcomes After Atrial Fibrillation Ablation
Okawa, K., Sogo, M., Morimoto, T., Tsushima, R., Sudo, Y., Saito, E., Ozaki, M., & Takahashi, M. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028482 · Cited by 23
Resumption of Anticoagulation After Intracranial Hemorrhage
da Silva, I. R. F., & Frontera, J. A. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0477-y · Cited by 24
Risks of Bleeding and Stroke Based on CHA2DS2‐VASc Scores in Japanese Patients With Atrial Fibrillation: A Large‐Scale Observational Study Using Real‐World Data
Maeda, T., Nishi, T., Funakoshi, S., Tada, K., Tsuji, M., Satoh, A., Kawazoe, M., Yoshimura, C., & Arima, H. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014574 · Cited by 23
The Predictive Value of CHA2DS2-VASc Score on In-Hospital Death and Adverse Periprocedural Events Among Patients With the Acute Coronary Syndrome and Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention: A 10-Year National Inpatient Sample (NIS) Analysis
Borovac, J. A., Kwok, C. S., Mohamed, M., Fischman, D. L., Savage, M. P., Alraies, M. C., Kalra, A., Nolan, J., Zaman, A., Ahmed, J. M., et al. (2020) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2020.08.003 · Cited by 24
Risk of developing diabetes in patients with atrial fibrillation taking non‐vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study
Huang, H., Liu, P. P., Lin, S., Hsu, J., Peng, C. C., Munir, K. M., Wu, T., Yeh, J., Loh, C., & Tu, Y. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14243 · Cited by 23
Cierre de la orejuela izquierda por ictus pese a la anticoagulación oral (ictus resistente): resultados del registro Amplatzer Cardiac Plug
Cruz‐González, I., González-Ferreiro, R., Freixa, X., Gafoor, S. A., Shakir, S., Omran, H., Berti, S. L., Santoro, G., Kefer, J., Landmesser, U., et al. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.02.018 · Cited by 23
Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons
Chee, J. L. Y., Guan, X. L., Lee, J. Y., Dong, B., Leong, S. M., Ong, E. H., Liou, A. K. F., & Lim, T. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4413-4 · Cited by 23
Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey
Lip, G. Y. H., Bongiorni, M. G., Dobreanu, D., Lewalter, T., Svendsen, J. H., & Blomström‐Lundqvist, C. (2013) · EP Europace · doi:10.1093/europace/eut292 · Cited by 21
Self-citation
Electrophysiology and heart rhythm disorders in older adults.
Goyal, P., & Rich, M. W. (2016) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2016.08.001 · Cited by 23
Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk
Kawakami, H., Nolan, M. T., Phillips, K. P., Scuffham, P., & Marwick, T. H. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.08.008 · Cited by 22
Validation of the 4‐Item PRECISE‐DAPT Score: A SWEDEHEART Study
Wester, A., Mohammad, M. A., Olivecrona, G. K., Holmqvist, J., Yndigegn, T., & Koul, S. M. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020974 · Cited by 22
Management of Chronic Non-Cancer Pain: a Framework
Nadeau, S. E., & Lawhern, R. A. (2022) · Pain Management · doi:10.2217/pmt-2022-0017 · Cited by 27
Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps
Leader, A., Cate, H. T., Spectre, G., Beckers, E. A. M., & Falanga, A. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.09.014 · Cited by 22
Incremental Prognostic Impact of Peripheral Microvascular Endothelial Dysfunction on the Development of Ischemic Stroke
Toya, T., Sara, J. D. S., Ahmad, A., Nardi, V., Taher, R., Lerman, L. O., & Lerman, A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015703 · Cited by 22
Use of Anticoagulation Agents After Traumatic Intracranial Hemorrhage
Divito, A., Kerr, K. A., Wilkerson, C. G., Shepard, S., Choi, A., & Kitagawa, R. S. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.10.173 · Cited by 22
Impact of Heart Failure Type on Thromboembolic and Bleeding Risk in Patients With Atrial Fibrillation on Oral Anticoagulation
Mentias, A. G., Briasoulis, Α., Shantha, G., Alvarez, P. A., & Vaughan‐Sarrazin, M. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.027 · Cited by 22
Antithrombotic Management of Atrial Fibrillation in the Elderly
Edholm, K., Ragle, N., & Rondina, M. T. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.11.012 · Cited by 21
Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study
Mochalina, N., Jöud, A., Carlsson, M., Sandberg, M., Själander, A., Juhlin, T., & Svensson, P. J. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.02.023 · Cited by 21
External validation of the breast reconstruction risk assessment calculator
Khavanin, N., Qiu, C. S., Mlodinow, A. S., Vu, M. M., Dorfman, R. G., Fine, N. A., & Kim, J. Y. S. (2017) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2017.04.010 · Cited by 21
A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany
Birkemeyer, R., Müller, A., Wahler, S., & von der Schulenburg, J.-M. (2020) · Health Economics Review · doi:10.1186/s13561-020-00274-z · Cited by 21
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease
Benz, A. P., Healey, J. S., Chin, A., Commerford, P., Marsden, T., Karthikeyan, G., McIntyre, W. F., Wong, J. A., Damasceno, A. A. M., Hohnloser, S. H., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa344 · Cited by 21
Impact of Fall Risk and Direct Oral Anticoagulant Treatment on Quality-Adjusted Life-Years in Older Adults with Atrial Fibrillation: A Markov Decision Analysis
Wei, W., Rasu, R. S., Hernández‐Muñoz, J. J., Flores, R. J., Rianon, N. J., Hernández-Vizcarrondo, G. A., & Brown, A. T. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00870-6 · Cited by 21
Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study
Korsholm, K., Valentin, J. B., Damgaard, D., Diener, H., Camm, A. J., Landmesser, U., Hildick‐Smith, D., Johnsen, S. P., & Nielsen‐Kudsk, J. E. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.06.065 · Cited by 21
Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
Dzeshka, M. S., & Lip, G. Y. H. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.10.017 · Cited by 21
Self-citation
Resuming anticoagulant therapy after intracerebral bleeding
Becattini, C., Sembolini, A., & Paciaroni, M. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.05.012 · Cited by 22
Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry
Cruz‐González, I., Ince, H., Kische, S., Schmitz, T., Schmidt, B., Gori, T., Foley, D., Potter, T. J. R. D., Tschishow, W. N., Vireca, E., et al. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.02.008 · Cited by 21
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post–PCI in Patients With Atrial Fibrillation and Diabetes
Mæng, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., Kimura, T., Lip, G. Y. H., Oldgren, J., ten Berg, J. M., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.07.059 · Cited by 23
Self-citation
Putting risk prediction in atrial fibrillation into perspective
Piccini, J. P., & Singer, D. E. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs031 · Cited by 21
New horizons: managing antithrombotic dilemmas in patients with cerebral amyloid angiopathy
Kelly, J. (2021) · Age and Ageing · doi:10.1093/ageing/afaa275 · Cited by 20
Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
Zappulla, P., & Calvi, V. I. (2021) · TH Open · doi:10.1055/s-0041-1730035 · Cited by 21
Comparative efficacy and safety of different catheter ablation strategies for persistent atrial fibrillation: a network meta-analysis of randomized clinical trials
Saglietto, A., Ballatore, A., Gaïta, F., Scaglione, M., Ponti, R. D., Ferrari, G. M. D., & Anselmino, M. (2021) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcab066 · Cited by 20
The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations
Bekiaridou, Α., Κάρτας, Α., Moysidis, D. V., Papazoglou, Α. S., Baroutidou, A., Papanastasiou, A., & Giannakoulas, G. A. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09713-0 · Cited by 21
Low performance of bleeding risk models in the very elderly with atrial fibrillation using vitamin K antagonists
Focks, J. J., van Vugt, S. P. G., Albers-Akkers, M. T., Lamfers, E. J. P., Vries, L. M. B., Verheugt, F. W. A., & Brouwer, M. A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13361 · Cited by 20
Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation
Molnar, A. O., & Sood, M. M. (2017) · Seminars in Dialysis · doi:10.1111/sdi.12637 · Cited by 21
Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis
Aronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al‐Khalili, F., Friberg, L., Frykman, V., & Levin, L. (2017) · EP Europace · doi:10.1093/europace/eux002 · Cited by 20
Self-citation
Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
Nashef, S. A. M., Fynn, S. P., Abu-Omar, Y., Spyt, T. J., Mills, C., Everett, C., Fox-Rushby, J. A., Singh, J., Dalrymple-Hay, M. J. R., Sudarshan, C., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy165 · Cited by 20

Authors: Friberg, L., Rosenqvist, M., & Lip, G. Y. H.
Affiliations: Danderyds sjukhus (SE)
Karolinska Institutet (SE)
Birmingham City Hospital (GB)
Corresponding author: Lip, Gregory Y.H.
ORCID: Friberg, Leif
Lip, Gregory Y.H.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2012-01-13
Volume: 33
Issue: 12
Pages: 1500-1510
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/ehr488
OpenAlex: W2124601103
Cited by: 1,192
References: 48
Citations by year: 2026: 37 · 2025: 60 · 2024: 74 · 2023: 81 · 2022: 112 · 2021: 99 · 2020: 100 · 2019: 99 · 2018: 78 · 2017: 99 · 2016: 75 · 2015: 99 · 2014: 72 · 2013: 68 · 2012: 35
FWCI: 56.38
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Stockholms Läns Landsting
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, stroke risk stratification, bleeding risk stratification, CHA2DS2-VASc score, HAS-BLED score, thromboembolism, intracranial hemorrhage, risk factors, peripheral arterial disease, oral anticoagulants, thyroid dysfunction, hyperthyroidism, concordance index
MeSH terms: Adult, Aged, Anticoagulants, Atrial Fibrillation, Female, Hemorrhage, Humans, Male, Middle Aged, Risk Factors, Sweden, Thromboembolism, Cohort Studies, Risk Assessment, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks